NCT02501356View on ClinicalTrials.gov

Effects of ISOThrive on Bodyweight, Body Composition, Hunger/Satiety and Cardiac Risk Measures in Overweight Adults

NACompletedINTERVENTIONAL
Enrollment

103

Participants

Timeline

Start Date

April 30, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Obesity
Interventions
DIETARY_SUPPLEMENT

ISOThrive Supplement

Consumption of ISOThrive supplements for 3 months

DIETARY_SUPPLEMENT

Placebo Supplement

Consumption of Placebo supplement (Magnesium stearate or methylcellulose) for 3 months

Trial Locations (1)

06418

Yale-Griffin Prevention Research Center, Derby

All Listed Sponsors
collaborator

ISOThrive Inc.

INDUSTRY

lead

Griffin Hospital

OTHER

NCT02501356 - Effects of ISOThrive on Bodyweight, Body Composition, Hunger/Satiety and Cardiac Risk Measures in Overweight Adults | Biotech Hunter | Biotech Hunter